Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Diabetic women get less intense treatment of heart disease than men

17.06.2008
Women with type 2 diabetes and heart disease have poorer control of both diseases and receive less intensive medical treatment than do men, a large new study found. The results have been presented Sunday, June 15, at The Endocrine Society’s 90th Annual Meeting in San Francisco.

The findings of the study, performed at three German universities, may indicate why death due to heart disease has decreased among diabetic men but not in women with type 2 diabetes, said the study’s primary author. Ioanna Gouni-Berthold, MD, professor of medicine at the University of Cologne, led the study.

“Our study shows that in patients with diabetes there is a clear disparity between men and women in the control and treatment of important modifiable risk factors for cardiovascular disease,” Gouni-Berthold said. “Women have worse control of their blood pressure, blood sugar and cholesterol levels compared to men and are given cholesterol-lowering medications less often.”

Gouni-Berthold and researchers from the University of Bonn and University of Homburg studied nearly 45,000 people with type 2 diabetes treated as outpatients by private-practice physicians from 2002 to 2003. Of the patients, 9,521 men and 8,050 women had heart and vascular disease.

There were no gender differences in the intensity of medication management or most heart disease risk factors among diabetic patients who did not have heart disease, the study found. However, in the group with cardiovascular disease, women were 44 percent more likely than men to have high LDL (“bad”) cholesterol, yet 15 percent less likely to receive lipid-lowering medications, the authors reported. Women also were 19 percent more likely than men to have uncontrolled high blood pressure.

In addition, women were 15 percent more likely to have poor long-term control of their blood glucose (sugar) level, as shown by a hemoglobin A1c blood test above 8 percent. The recommended A1c level for adults with type 2 diabetes is less than 7 percent.

The findings are cause for concern, according to Gouni-Berthold, because there is evidence that diabetes cancels the protective effect of female sex on the risk of heart disease.

“More aggressive treatment of cardiovascular disease in women with diabetes may improve the gender disparity in cardiovascular disease mortality,” she said. “Patients should speak with their doctors about the intensity of treatment modalities.”

The study patients were part of the German DUTY (Diabetes mellitus needs unrestricted evaluation of patient data to yield treatment progress) Registry. Merck Sharp & Dohme provided a research grant that funded the registry. However, the pharmaceutical company had no influence on data analysis, according to Gouni-Berthold.

Patrick Honecker | alfa
Further information:
http://www.uk-koeln.de/kliniken/innere2/

Further reports about: Cardiovascular Diabetes Gouni-Berthold Heart Treatment blood

More articles from Life Sciences:

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

A new dead zone in the Indian Ocean could impact future marine nutrient balance

06.12.2016 | Earth Sciences

Significantly more productivity in USP lasers

06.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>